Creo Medical Group plc

('Creo' or 'the Company')

Change of Registered Address

Chepstow, South Wales - 11 September 2017 - Creo Medical Group plc (AIM: CREO), a medical device company focused on the emerging field of surgical endoscopy, today announces that it has changed its Registered Office Address to Block B, Beaufort Park, Chepstow, NP16 5TY, with immediate effect.

Contacts

Creo Medical:

Cenkos:

FTI Consulting:

Roseanne Varner

+44 (0)129 160 6005 roseanne.varner@creomedical.com

Ivonne Cantu / Camilla Hume (NOMAD)

Michael Johnson / Russell Kerr (Sales)

+44 (0)207 397 8900

Brett Pollard / Mo Noonan

+44 (0)203 727 1000

creo@fticonsulting.com

About Creo Medical

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive surgical devices, by bringing advanced energy to endoscopy. The Company's mission is to improve patient outcomes by applying microwave and radiowave energy to surgical endoscopy. Creo has developed CROMA, an electrosurgical platform that combines bipolar radiofrequency for precise localised cutting and microwave for controlled coagulation. This technology provides physicians with flexible, accurate and controlled surgical solutions.

The Company's strategy is to bring the CROMA surgical system to market through a suite of medical devices which the Company has designed, initially for the emerging field of GI therapeutic endoscopy, an area with high unmet needs. The CROMA system will be developed further for bronchoscopy and laparoscopy procedures. The Company believes its technology can impact the landscape of surgery and endoscopy by providing safer, less-invasive and more cost-efficient option of treatment.

For more information about Creo Medical please see our website, www.creomedical.com.

Creo Medical Group plc published this content on 11 September 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 11 September 2017 13:13:07 UTC.

Original documenthttp://otp.investis.com/clients/uk/creo_medical/rns/regulatory-story.aspx?cid=2071&newsid=923903

Public permalinkhttp://www.publicnow.com/view/B401A726826C377BE88D4104769CBCC92B6D482A